back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-04-23 22:26 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+25,450 vol |
47,461 | |
| Filed 2019-04-23 18:46 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+25,450 vol |
||
| Filed 2019-04-23 18:46 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+25,450 vol |
47,461 | |
| Filed 2019-04-23 18:45 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$56,574
+38,226 vol $1.48 each |
114,221 | |
| Filed 2019-04-18 11:55 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$500.31
+459 vol $1.09 each |
8,073 | |
| Filed 2019-04-17 13:09 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,635 vol |
7,614 | |
| Filed 2019-04-17 13:08 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,187 vol |
22,011 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.20
+320 vol $1.56 each |
4,979 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$500.71
+311 vol $1.61 each |
4,659 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.95
+303 vol $1.65 each |
4,348 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.81
+331 vol $1.51 each |
4,045 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.81
+331 vol $1.51 each |
3,714 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.80
+196 vol $2.55 each |
3,383 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$463.61
+179 vol $2.59 each |
||
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.41
+179 vol $2.79 each |
3,187 | |
| Filed 2018-08-28 Tx date 2018-08-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,151 vol |
3,008 | |
| Filed 2018-08-28 Tx date 2018-08-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,151 vol |
27,198 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.87
+193 vol $2.59 each |
857 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.80
+210 vol $2.38 each |
664 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$498.96
+216 vol $2.31 each |
454 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$498.96
+168 vol $2.97 each |
238 | |
| Filed 2018-04-20 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$250.60
+70 vol $3.58 each |
70 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,406
+40,625 vol $3.53 each |
||
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,406
+40,625 vol $3.53 each |
75,995 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,745 vol |
||
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,745 vol |
29,349 | |
| Filed 2017-09-25 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,594 vol |
9,594 | |
| Filed 2017-09-14 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-14 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-14 Tx date 2017-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+8,604 vol |
||
| Filed 2017-09-14 Tx date 2017-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+8,604 vol |
8,604 | |
| Filed 2017-09-14 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$185,338
+35,370 vol $5.24 each |
35,370 |